Polychromatic, diversely-sized particles for angiography
A particle and blood vessel technology, applied in the field of detection of blood vessel leakage and blood flow, can solve the problems of leaking retina, subspace, fluorescein leakage, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0074] Embodiment 1 Materials and methods
[0075] Materials: Poly(D,L-lactide-co-glycolide) (PLGA), Mw = 10,000 Da (intrinsic viscosity: 0.17 dL / g), purchased from Birmingham Polymers (Durect Corporation, Pelham, AL). Indocyanine green, sodium fluorescein and poly(vinyl alcohol) (PVA) were obtained from Sigma-Aldrich (St Louis, MO). Dichloromethane was obtained from Acros (Morris Plains, NJ). All other chemicals were of analytical grade and obtained from local sources.
[0076]Nanoparticle formulation: PLGA nanoparticles were prepared using a slightly modified nanoprecipitation technique (Chorny et al., 2002, Journal of Controlled Release). Briefly, polymer (70 mg) and indocyanine green or fluorescein (30 mg) were dissolved in a mixture of 15.5 mL acetone, 4 mL ethanol and 0.5 mL dichloromethane and poured into the filtered 1% In the PVA aqueous phase, distilled water (40 ml) was added under moderate stirring. After evaporating the organic phase overnight at 37°C using a ...
Embodiment 2
[0082] Example 2: Detection of blood-retinal barrier dysfunction
[0083] This example shows the detection of blood-retinal barrier damage using a composition of differently sized, differently labeled particles.
[0084] Filtration studies illustrate different particle sizes
[0085] Such as Figure 5 As shown in , particle formulations of different particle sizes were produced with different chromophores. The separation and detection of particles of different sizes is effected by the filtration of membranes with different pore sizes. Therefore, a composition of two particle groups was prepared, as Figure 5 shown in (lower row, far right). The composition is shown in Figure 5 (lower row, middle). Compositions comprising smaller, fluorescein-labeled PLGA particles are shown in separate form at Figure 5 (lower row, left), and larger indocyanine green PLGA particles are shown in Figure 5 (bottom, right). Thus, the composition comprises a mixture of fluorescein PLGA a...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 